Pacific Biosciences Of California (PACB) Leases (2017 - 2025)
Historic Leases for Pacific Biosciences Of California (PACB) over the last 10 years, with Q3 2025 value amounting to $42.6 million.
- Pacific Biosciences Of California's Leases rose 14552.01% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year increase of 14552.01%. This contributed to the annual value of $16.1 million for FY2024, which is 5063.05% down from last year.
- According to the latest figures from Q3 2025, Pacific Biosciences Of California's Leases is $42.6 million, which was up 14552.01% from $43.5 million recorded in Q2 2025.
- Pacific Biosciences Of California's Leases' 5-year high stood at $46.6 million during Q4 2021, with a 5-year trough of $16.1 million in Q4 2024.
- Its 5-year average for Leases is $35.7 million, with a median of $38.2 million in 2023.
- As far as peak fluctuations go, Pacific Biosciences Of California's Leases tumbled by 5063.05% in 2024, and later skyrocketed by 14552.01% in 2025.
- Pacific Biosciences Of California's Leases (Quarter) stood at $46.6 million in 2021, then dropped by 14.7% to $39.8 million in 2022, then dropped by 18.03% to $32.6 million in 2023, then tumbled by 50.63% to $16.1 million in 2024, then soared by 164.64% to $42.6 million in 2025.
- Its Leases was $42.6 million in Q3 2025, compared to $43.5 million in Q2 2025 and $44.4 million in Q1 2025.